J
Jacoline E C Bromberg
Researcher at Erasmus University Rotterdam
Publications - 103
Citations - 10921
Jacoline E C Bromberg is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Primary central nervous system lymphoma & Rituximab. The author has an hindex of 31, co-authored 95 publications receiving 9357 citations. Previous affiliations of Jacoline E C Bromberg include Erasmus University Medical Center & Utrecht University.
Papers
More filters
Journal ArticleDOI
Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
Avinash G. Dinmohamed,Matthijs van der Meulen,Otto Visser,Jeanette K. Doorduijn,Jacoline E C Bromberg +4 more
TL;DR: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Journal ArticleDOI
OS03.6.A Rituximab in primary CNS lymphoma - long term follow-up of the phase III HOVON 105/ALLG NHL 24 Study
Jacoline E C Bromberg,Samar Issa,B. van der Holt,Monique C. Minnema,Tatjana Seute,Marc Durian,Gavin Cull,M. W. M. van der Poel,Wendy Stevens,Josée M. Zijlstra,Marcel Nijland,K. Mason,Aart Beeker,Dieta Brandsma,Martin J. van den Bent,M. González,Daphne de Jong,Jeanette K. Doorduijn +17 more
TL;DR: The results of this study do not support the use of rituximab with MBVP in the treatment of PCNSL, and in the modified-ITT population the authors found no statistically significant benefit of the addition of r ituximabs to MBVP on EFS, PFS and OS.
Book ChapterDOI
Anaplastic Oligodendrogliomas and Mixed Gliomas
TL;DR: It is now clear that AOD and AOA with this combined loss of 1p/19q do not only have a better response to chemotherapy, but they also have a more indolent clinical behavior and a longer lasting response to radiotherapy (RT).